Anti-cervical cancer vaccine by SII Current Affairs, GK & News

SII: Anti-cervical cancer vaccine

On July 12, 2022, the CEO of Serum Institute of India (SII) Adar Poonawalla announced company’s plans to roll out its indigenously-developed vaccine for the prevention of cervical cancer among women. Highlights The Drugs Controller General of India (DCGI) has also accorded the market authorisation to SII for manufacturing the vaccine for cervical cancer. It will be ..

Month: 

Category: 

Topics: